금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
Aussie Dollar breaks 0.70 as RBA inflation warning fuels two-week high
The Australian Dollar registers solid gains versus the Greenback, climbing above 0.7000 and hitting ...
Dow Jones Futures Rise; SpaceX Crushes Views, Eyes Tesla Merger; Supermicro Reports Blowout Sales
The Dow and S&P 500 reclaimed their 50-day line. SpaceX crushed earnings views and is mulling a Tesl...
Euro gains little as ZEW sentiment falls short of forecast
Economic sentiment in the ZEW survey fell well short of forecast, and EUR/USD ended Tuesday about wh...
Applied Digital and TeraWulf Climb 5% as Oversold AI Capacity Names Bounce; Cipher Digital Edges Higher
Applied Digital and TeraWulf are bouncing hard on zero company news, and that round trip reveals a structural tension in how the market prices contracted AI capacity against pure sentiment flows.
Haemonetics upgraded to Buy at BofA on supply deal with CSL
Generac Stock Surges on Amazon Data Center Deal. Why It’s a Game-Changer.
The backup power company disclosed a long-term deal to provide Amazon generators for its data centers.
10 mid-cap healthcare stocks with the strongest momentum grades
Pending home sales rise less than expected in August
SiTime receives Overweight rating due to data center demand and M&A support: MS
10 large and mega-cap U.S. healthcare stocks with the strongest momentum grades
Best Momentum Stocks to Buy for September 17th
MSGM, ASMB and MTG made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 17th, 2026.
Nebius Stock and IREN Gain. AI Neoclouds Are Flexing Their Pricing Power.
There’s more evidence that computing power is in enormous demand and artificial-intelligence chips are holding their value. Nebius recently informed customers that it will raise its on-demand rental ...
These utilities stocks have strong valuation grades
Small-cap stocks with strong momentum grades and triple-digit YTD gains
Moderna Climbs 6% as Cancer Vaccine Trade Extends a 137% Month; BioNTech and Novavax Edge Higher
Moderna has nearly tripled in a single month without a single new trial result or analyst upgrade to explain Thursday's continued surge, and the one clue hiding in a quiet peer stock reveals exactly w ...